These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6209338)

  • 21. Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: a novel C1q binding assay.
    Leatherbarrow RJ; Dwek RA
    Mol Immunol; 1984 Apr; 21(4):321-7. PubMed ID: 6610105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune complex assays and stored normal human sera.
    Julkunen I; Lindström P; Wager O; Penttinen K
    J Immunol Methods; 1983 Jan; 56(2):167-74. PubMed ID: 6600766
    [No Abstract]   [Full Text] [Related]  

  • 24. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
    Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C1q microtiter plate ELISA system for detecting circulating immune complexes and its application of testing the sera in neurological diseases.
    Araga S; Irie H; Takahashi K
    Jpn J Exp Med; 1984 Feb; 54(1):23-7. PubMed ID: 6384588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A solid phase C1q enzyme assay for circulating immune complexes adapted for routine clinical laboratory testing.
    James K; Vahey A; Robinson M; Marder R
    Am J Clin Pathol; 1983 Oct; 80(4):445-52. PubMed ID: 6353904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases.
    Wener MH; Uwatoko S; Mannik M
    Arthritis Rheum; 1989 May; 32(5):544-51. PubMed ID: 2785797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformational changes in C1q after binding to immune complexes: detection of neoantigens with monoclonal antibodies.
    Golan MD; Burger R; Loos M
    J Immunol; 1982 Aug; 129(2):445-7. PubMed ID: 6177765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C1q binding and C1q deviation assays using enzyme labelled C1q.
    Smith GW; Myles MJ; Simpson IJ
    J Immunol Methods; 1984 Feb; 67(1):167-72. PubMed ID: 6366065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A substrate amplification system for enzyme-linked immunoassays. Demonstration of its general applicability to ELISA systems for detecting antibodies and immune complexes.
    Carr RI; Mansour M; Sadi D; James H; Jones JV
    J Immunol Methods; 1987 Apr; 98(2):201-8. PubMed ID: 3494782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
    Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
    Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of circulating immune complexes by a C1q-microplate ELISA system.
    Singh VK; Tingle AJ
    J Immunol Methods; 1982; 50(1):109-14. PubMed ID: 6177790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis.
    Siegert CE; Daha MR; van der Voort EA; Breedveld FC
    Arthritis Rheum; 1990 Nov; 33(11):1646-54. PubMed ID: 2146965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
    Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
    J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
    Rossen RD; Crane MM; Morgan AC; Giannini EH; Giovanella BC; Stehlin JS; Twomey JJ; Hersh EM
    Cancer Res; 1983 Jan; 43(1):422-9. PubMed ID: 6600161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of solid-phase C1Q to remove soluble antigen/antibody complexes in an inhibition ELISA for streptococcal cell membrane antigens.
    Zelman ME; Lange CF
    J Immunoassay; 1990; 11(4):545-54. PubMed ID: 2283393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
    Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C1q and C3 in bronchoalveolar lavage fluid from patients with summer-type hypersensitivity pneumonitis.
    Soda K; Ando M; Sakata T; Sugimoto M; Nakashima H; Araki S
    Chest; 1988 Jan; 93(1):76-80. PubMed ID: 3257185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C1q binding by a high affinity anti-fluorescein murine monoclonal IgM antibody and monomeric subunits.
    Swanson SM; Dombrink-Kurtzman MA; Voss EW
    Mol Immunol; 1988 Jun; 25(6):545-54. PubMed ID: 2459610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.